临床实践指南:耳鸣更新版
该指南由美国耳鼻咽喉头颈外科学会制定,针对18岁及以上持续且困扰性耳鸣成人患者,提供循证推荐。指南强调区分困扰性与非困扰性耳鸣、评估自伤风险、不常规进行神经影像学检查,并推荐认知行为疗法、助听器评估等,反对常规使用药物或膳食补充剂。
要点
- 区分困扰性与非困扰性耳鸣,并评估自伤风险。
- 不常规进行神经影像学检查,除非有特定警示特征。
- 推荐认知行为疗法和助听器评估,反对常规药物或补充剂。
核心结论
- 指南为持续且困扰性耳鸣成人患者提供循证管理框架,强调区分困扰性、评估自伤风险,并推荐认知行为疗法等干预。
研究设计与样本
- 指南由美国耳鼻咽喉头颈外科学会采用其临床实践指南开发手册(第3版)制定,专家组包括耳鼻咽喉科医生、听力学家、神经耳科医生等多学科成员。
主要发现
- 指南针对持续6个月或更长的困扰性耳鸣成人患者(18岁及以上)。
- 指南更新组对关键行动声明进行了强推荐、推荐、反对推荐或提供选项。
关键数值与推荐
- 强推荐:区分困扰性与非困扰性耳鸣(KAS 2)。
- 强推荐:询问自伤风险(KAS 3)。
- 强推荐:不获取神经影像学检查以评估耳鸣,除非有特定警示特征(KAS 6)。
- 推荐:进行针对性病史和体格检查(KAS 1)、全面听力学评估(KAS 5)、教育患者(KAS 7)、推荐助听器评估(KAS 8)、推荐人工耳蜗评估(KAS 9)、推荐认知行为疗法(KAS 11)、评估并记录干预结果(KAS 15)。
- 反对推荐:不常规推荐抗抑郁药、抗惊厥药、抗焦虑药或鼓室内药物(KAS 12);不推荐膳食补充剂(KAS 13);不推荐重复经颅磁刺激(KAS 14A)。
临床怎么用
- 临床医生应区分困扰性与非困扰性耳鸣,并评估自伤风险。
- 不常规进行神经影像学检查,除非有特定警示特征。
- 推荐认知行为疗法、助听器评估和人工耳蜗评估(符合听力学标准时)。
- 反对常规使用药物、膳食补充剂或重复经颅磁刺激治疗耳鸣。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Tinnitus is the perception of sound without an external source. More than 50 million people in the United States have reported experiencing tinnitus, resulting in an estimated prevalence of 10% to 15% in adults. The focus of this guideline is on tinnitus that is both bothersome and persistent (lasting 6 months or longer), which often negatively affects the patient's quality of life. The target audience for the guideline is any clinician, including allied health professionals, involved in managing patients with tinnitus. The target patient population is limited to adults (18 years and older) with tinnitus that is persistent and bothersome. PURPOSE: The purpose of this guideline is to provide and update evidence-based recommendations for clinicians managing patients with tinnitus. This guideline provides clinicians with a logical framework to improve patient care and mitigate the personal and social effects of persistent, bothersome tinnitus. It discusses the evaluation of patients with tinnitus, including selection and timing of diagnostic testing and specialty referral to identify potential underlying treatable pathology. It then focuses on the treatment of patients with persistent tinnitus, with recommendations to guide the measurement of the effect of tinnitus and to determine the most appropriate interventions to improve symptoms and quality of life for people with tinnitus and associated comorbidities. METHODS: This guideline was developed using the 55-page protocol published as the American Academy of Otolaryngology-Head and Neck Surgery Foundation's Clinical Practice Guideline Development Manual (3rd edition), which summarizes the methodology for assessments of current data, topic prioritization, development of key action statements (KASs), application of value judgments, and related procedures. The guideline group was represented by adult otolaryngologists, audiologists, otologists/neurotologists, a geriatrician, a behavioral neuroscientist, a neurologist, a radiologist, a psychiatrist, an internist, a nurse practitioner, an otolaryngology resident physician, and a consumer advocate who represented participating, national professional organizations. ACTION STATEMENTS: The Guideline Update Group made strong recommendations for the following Key Action Statements (KAS): Clinicians should distinguish patients with bothersome tinnitus from patients with non-bothersome tinnitus (KAS 2). Clinicians should inquire about risks for self-harm in a patient with bothersome tinnitus (KAS 3). Clinicians should not obtain neuroradiologic imaging in patients with tinnitus specifically to evaluate the tinnitus unless specific concerning features are present (KAS 6). The Guideline Update Group made recommendations for the following KASs: Clinicians should perform a targeted history and physical examination at the initial evaluation of a patient with tinnitus (KAS 1). Clinicians should obtain a comprehensive audiological evaluation in patients with tinnitus (KAS 5). Clinicians should educate patients with tinnitus about the natural history and effects of, and management strategies for tinnitus (KAS 7). Clinicians should recommend a hearing aid evaluation for patients with hearing difficulties and persistent, bothersome tinnitus (KAS 8). Clinicians should refer patients with persistent, bothersome tinnitus for cochlear implant evaluation when they meet audiologic criteria for referral (KAS 9). Clinicians should recommend Cognitive Behavioral Therapy (CBT) to patients with persistent, bothersome tinnitus (KAS 11). Clinicians or their designee should assess and document outcomes of interventions in patients with persistent, bothersome tinnitus (KAS 15). The Guideline Update Group made recommendations against for the following KASs: Clinicians should not routinely recommend antidepressants, anticonvulsants, anxiolytics, or intratympanic medications for a primary indication of treating persistent, bothersome tinnitus (KAS 12). Clinicians should not recommend dietary supplements for the primary indication of persistent, bothersome tinnitus (KAS 13). Clinicians should not recommend repetitive transcranial magnetic stimulation (rTMS) for the treatment of patients with persistent, bothersome tinnitus (KAS 14A). The Guideline Update Group offered options for the following KASs: Clinicians may inquire about somatosensory features in patients with persistent, bothersome tinnitus (KAS 4). Clinicians may recommend sound enrichment to patients with persistent, bothersome tinnitus (KAS 10). Clinicians may offer bimodal neuromodulation to patients with persistent, bothersome tinnitus (KAS 14B).
引用
- Adams ME, Cramer JD, Tunkel DE, et al. Clinical Practice Guideline: Tinnitus Update. Otolaryngol Head Neck Surg. 2026. PMID: 42861423. doi:10.1002/ohn.70417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。